Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl.
Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer
With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities to the scale-up of complex cell-based therapies.
Company Details
- Employees
- 5
- Address
- Via Maestri Del Lavoro, 4, Medolla,emilia-Romagna 41036,italy
- Phone
- 39053549307
- in****@****rand.it
- Industry
- Biotechnology
- Website
- rigenerand.it
- Keywords
- Medical Devices, 3D Culture Systems, Cancer, Regenerative Medicine, Precision Medicine, 3D Diagnostics, Cell Therapy, Gene Therapy, cGMP Facility, Cell Factory.
- HQ
- Medolla, Emilia-Romagna
Rigenerand Srl Questions
Rigenerand Srl's helpline number is 39053549307
Rigenerand Srl's website is rigenerand.it
Rigenerand Srl's LinkedIn profile is https://it.linkedin.com/company/rigenerand
Rigenerand Srl has
5 employees.
View email and phone details for 5
employees at Rigenerand Srl.
Rigenerand Srl's industry is
Biotechnology
Rigenerand Srl's top competitors are
Rigeneralab Centro Di Medicina Rigenerativa,
Enea Tech E Biomedical,
Genenta Science (Nasdaq: Gnta),
Generon S.p.a.,
Ncnbio Srl,
Evotec,
Molmed Now Part Of Agc Biologics,
Cellply,
Centre For Regenerative Medicine Modena,
Holostem S.r.l..
Rigenerand Srl's support email address is info@rigenerand.it
Rigenerand Srl's categories are Biotechnology
